A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A
Active, not recruiting · NCT05911763
Conditions: Hemophilia A
At a glance
- Research payments reported, 2025
- $201,594
- U.S. investigators named
- 27
- Sites paid
- 26
- Planned or actual enrollment
- 200
About the trial
- Sponsor
- Sanofi
- Tested
- Efanesoctocog Alfa BIVV001 (drug)
- Dates
- Started 2023-06-30; completion 2030-09-17
- Results posted
- Not yet
This is a prospective, observational, multi-center longitudinal cohort study to describe the real-world effectiveness, safety and treatment usage of efanesoctocog alfa in patients with hemophilia A treated per standard of care in the US and Japan. Patients will be enrolled in the study after the introduction of efanesoctocog alfa in the hemophilia treatment landscape in each study country. Decision to initiate treatment with commercially available efanesoctocog alfa will be made by the treating physician independently from the decision to include patients in the study. No study medication is provided. The data related to efanesoctocog alfa effectiveness, safety and usage will be collected…
From ClinicalTrials.gov, last updated 2026-09-29. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Sanofi US Services Inc. reported $201,594 in research payments for this study in 2025 (61 payments).
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Danielle Nance, MD Hematology · Gilbert, AZ
- Akshat Jain, MD Pediatric Hematology & Oncology · Redlands, CA
- Doris Quon, M.D. Hematology · Los Angeles, CA
- Amit Soni, M.D Pediatric Hematology & Oncology · Orange, CA
- Annette Von Drygalski, MD Hematology & Oncology · San Diego, CA
- Beth M. Warren, MD Pediatric Hematology & Oncology · Aurora, CO
- Allison P. Wheeler, M.D. Hematology · Aurora, CO
- Tung T. Wynn, M.D. Pediatric Hematology & Oncology · Gainesville, FL
- Janice M. Staber, M.D. Pediatric Hematology & Oncology · Iowa City, IA
- Lisa Boggio, MD Hematology & Oncology · Chicago, IL
- Jonathan C. Roberts, M.D. Pediatrics · Peoria, IL
- Kyle A. Davis, MD Pediatric Hematology & Oncology · Indianapolis, IN
- Cindy A. Leissinger Hematology & Oncology · New Orleans, LA
- Larissa Bornikova, M.D. Hematology & Oncology · Boston, MA
- Stacy E. Croteau, MD Pediatric Hematology & Oncology · Boston, MA
- Eric F. Grabowski, MD SCD Pediatric Hematology & Oncology · Boston, MA
- Angela C. Weyand, M.D. Pediatric Hematology & Oncology · Ann Arbor, MI
- Marshall A. Mazepa, M.D. Hematology & Oncology · Minneapolis, MN
- Spencer K. Sullivan, MD Pediatric Hematology & Oncology · Madison, MS
- Chittalsinh M. Raulji, MBBS Pediatric Hematology & Oncology · Omaha, NE
- Catherine E. Mcguinn, M.D. Pediatric Hematology & Oncology · New York, NY
- Cristina Tarango, M.D. Pediatric Hematology & Oncology · Cincinnati, OH
- Shannon C. Walker, M.D. Pathology · Nashville, TN
- Miguel A. Escobar, M.D. Hematology · Houston, TX
- Jessica Garcia, M.D. Pediatric Hematology & Oncology · Dallas, TX
- Yu-min P. Shen, MD Hematology & Oncology · Dallas, TX
- Barbara A. Konkle, MD Hematology · Seattle, WA
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Massachusetts General Hospital, MA $61,214
- Regents of University of Minnesota $15,970
- Loma Linda University $13,168
- Banner Casa Grande Medical Center, AZ $10,782
- University of California Davis Medical Center, CA $10,333
- University Florida $10,280
- Ut MD Anderson Cancer Center $8,923
- Versiti Wisconsin Inc $8,259
- The University of Texas Health Science Center at Houston $8,250
- Regents of the University of Minnesota $6,600
- Tulane University $5,328
- University of Iowa Hospital & Clinics, IA $5,000
- Vanderbilt University Medical Center, TN $4,946
- Rush University Medical Center, IL $4,854
- Center for Comprehensive Care and Diagnosis of Inherited Blood Disorder $4,807
- Boston Children's Hospital, MA $3,131
- University of Michigan Health System, MI $3,017
- Cincinnati Children's Hospital Medical Center, OH $2,527
- Weill Medical College of Cornell University Attn Joint Clinical Trials Office $2,501
- Bleeding and Clotting Disorders Institute $2,084
- Washington Center for Bleeding Disorders $2,066
- Indiana Hemophilia and Thrombosis Center $1,774
- Regents of the University of Colorado $1,757
- Orthopaedic Institute for Children $1,683
- La Center for Advanced Medical $1,500
- The Board of Regents of the University of Nebraska $842
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.